{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T01:03:23Z","timestamp":1780707803317,"version":"3.54.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BJC Rep"],"DOI":"10.1038\/s44276-025-00169-8","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T09:45:03Z","timestamp":1763631903000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["'Is it my last Christmas?\u2019 Using real-world data as a prompt to reflect on goal-concordant advanced lung cancer care\u2014a retrospective, longitudinal study"],"prefix":"10.1038","volume":"3","author":[{"given":"Clara","family":"Forrest","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Twomey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansoor","family":"Qayoumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Bryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dearbhaile C.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinead","family":"Noonan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karie","family":"Dennehy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siobh\u00e1n","family":"Gaynor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"O\u2019Dea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazel","family":"O\u2019Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seamus","family":"O\u2019Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"169_CR1","unstructured":"Cancer Research UK. Lung cancer statistics. 2024. https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/lung-cancer#heading-Zero."},{"key":"169_CR2","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S0140-6736(24)01029-8","volume":"404","author":"ML Meyer","year":"2024","unstructured":"Meyer ML, Fitzgerald BG, Paz-Ares L, Cappuzzo F, J\u00e4nne PA, Peters S, et al. New promises and challenges in the treatment of advanced non-small-cell lung cancer. Lancet. 2024;404:803\u201322.","journal-title":"Lancet"},{"key":"169_CR3","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1136\/bmj.308.6926.429","volume":"308","author":"IE Smith","year":"1994","unstructured":"Smith IE. Palliative chemotherapy for advanced non-small cell lung cancer. BMJ. 1994;308:429\u201330.","journal-title":"BMJ"},{"key":"169_CR4","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1200\/JCO.22.01990","volume":"41","author":"S Novello","year":"2023","unstructured":"Novello S, Kowalski DM, Luft A, G\u00fcm\u00fc\u015f M, Vicente D, Mazi\u00e8res J, et al. Pembrolizumab plus chemotherapy in squamous non-small-cell lung cancer: 5-year update of the phase III KEYNOTE-407 study. J Clin Oncol. 2023;41:1999\u20132006.","journal-title":"J Clin Oncol"},{"key":"169_CR5","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1200\/JCO.22.01989","volume":"41","author":"MC Garassino","year":"2023","unstructured":"Garassino MC, Gadgeel S, Speranza G, Felip E, Esteban E, D\u00f3mine M, et al. Pembrolizumab plus pemetrexed and platinum in nonsquamous non-small-cell lung cancer: 5-year outcomes from the phase 3 KEYNOTE-189 study. J Clin Oncol. 2023;41:1992\u20138.","journal-title":"J Clin Oncol"},{"key":"169_CR6","doi-asserted-by":"crossref","unstructured":"Cramer-van der Welle CM, Peters BJM, Schramel F, Klungel OH, Groen HJM, van de Garde EMW. Systematic evaluation of the efficacy-effectiveness gap of systemic treatments in metastatic nonsmall cell lung cancer. Eur Respir J. 2018;52:1801100.","DOI":"10.1183\/13993003.01100-2018"},{"key":"169_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-85696-3","volume":"11","author":"CM Cramer-van der Welle","year":"2021","unstructured":"Cramer-van der Welle CM, Verschueren MV, Tonn M, Peters BJM, Schramel F, Klungel OH, et al. Real-world outcomes versus clinical trial results of immunotherapy in stage IV non-small cell lung cancer (NSCLC) in the Netherlands. Sci Rep. 2021;11:6306.","journal-title":"Sci Rep"},{"key":"169_CR8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.lungcan.2022.10.003","volume":"174","author":"F Salomone","year":"2022","unstructured":"Salomone F, Di Costanzo F, Pecoraro G, Viscardi G, Viggiano A, Napolitano F, et al. Health-related quality of life is underestimated and underreported in phase III clinical trials in NSCLC. Lung Cancer. 2022;174:36\u201344.","journal-title":"Lung Cancer"},{"key":"169_CR9","doi-asserted-by":"crossref","unstructured":"Silverman R, Smith L, Sundar S. \u2018Is it my last Christmas dinner?\u2019 Survival of cancer patients having palliative chemotherapy during Christmas period. BMJ Support Palliat Care. 2014;4:A56.","DOI":"10.1136\/bmjspcare-2014-000654.159"},{"key":"169_CR10","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1136\/bmj.300.6737.1458","volume":"300","author":"ML Slevin","year":"1990","unstructured":"Slevin ML, Stubbs L, Plant HJ, Wilson P, Gregory WM, Armes PJ, et al. Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. BMJ. 1990;300:1458\u201360.","journal-title":"BMJ"},{"key":"169_CR11","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1136\/bmj.317.7161.771","volume":"317","author":"G Silvestri","year":"1998","unstructured":"Silvestri G, Pritchard R, Welch HG. Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews. BMJ. 1998;317:771\u20135.","journal-title":"BMJ"},{"key":"169_CR12","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0738-3991(01)00155-0","volume":"45","author":"MD Brundage","year":"2001","unstructured":"Brundage MD, Feldman-Stewart D, Cosby R, Gregg R, Dixon P, Youssef Y, et al. Cancer patients\u2019 attitudes toward treatment options for advanced non-small cell lung cancer: implications for patient education and decision support. Patient Educ Couns. 2001;45:149\u201357.","journal-title":"Patient Educ Couns"},{"key":"169_CR13","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/jjco\/hym147","volume":"38","author":"MK Kim","year":"2008","unstructured":"Kim MK, Lee JL, Hyun MS, Do YR, Song HS, Kim JG, et al. Palliative chemotherapy preferences and factors that influence patient choice in incurable advanced cancer. Jpn J Clin Oncol. 2008;38:64\u201370.","journal-title":"Jpn J Clin Oncol"},{"key":"169_CR14","volume":"3","author":"D Casarett","year":"2022","unstructured":"Casarett D, Lakis K, Ma JE, Gentry J, Fischer J, Ibrahim S, et al. Goal-concordant care: end-of-life planning conversations for all seriously ill patients. NEJM Catal. 2022;3:CAT.22.0271.","journal-title":"NEJM Catal"},{"key":"169_CR15","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1001\/jama.2017.1964","volume":"317","author":"VJ Dzau","year":"2017","unstructured":"Dzau VJ, McClellan MB, McGinnis JM, Burke SP, Coye MJ, Diaz A, et al. Vital directions for health and health care: priorities from a National Academy of Medicine Initiative. JAMA. 2017;317:1461\u201370.","journal-title":"JAMA"},{"key":"169_CR16","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1056\/NEJMp1908153","volume":"381","author":"SD Halpern","year":"2019","unstructured":"Halpern SD. Goal-concordant care\u2014searching for the Holy Grail. N Engl J Med. 2019;381:1603\u20136.","journal-title":"N Engl J Med"},{"key":"169_CR17","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.annonc.2022.12.013","volume":"34","author":"LE Hendriks","year":"2023","unstructured":"Hendriks LE, Kerr KM, Menis J, Mok TS, Nestle U, Passaro A, et al. Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34:358\u201376.","journal-title":"Ann Oncol"},{"key":"169_CR18","first-page":"d1933","volume":"342","author":"HM Buiting","year":"2011","unstructured":"Buiting HM, Rurup ML, Wijsbek H, van Zuylen L, den Hartogh G. Understanding provision of chemotherapy to patients with end stage cancer: qualitative interview study. BMJ. 2011;342:d1933.","journal-title":"BMJ"},{"key":"169_CR19","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1200\/JCO.21.02810","volume":"40","author":"A Gupta","year":"2022","unstructured":"Gupta A, Eisenhauer EA, Booth CM. The time toxicity of cancer treatment. J Clin Oncol. 2022;40:1611\u20135.","journal-title":"J Clin Oncol"},{"key":"169_CR20","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1093\/tbm\/ibab091","volume":"11","author":"HR Abrams","year":"2021","unstructured":"Abrams HR, Durbin S, Huang CX, Johnson SF, Nayak RK, Zahner GJ, et al. Financial toxicity in cancer care: origins, impact, and solutions. Transl Behav Med. 2021;11:2043\u201354.","journal-title":"Transl Behav Med"},{"key":"169_CR21","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1200\/JCO.2017.74.7907","volume":"36","author":"K Daily","year":"2018","unstructured":"Daily K. The toxicity of time. J Clin Oncol. 2018;36:300\u20131.","journal-title":"J Clin Oncol"},{"key":"169_CR22","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/JTO.0b013e3181c3f5f7","volume":"5","author":"N Singh","year":"2010","unstructured":"Singh N, Aggarwal AN, Behera D, Jindal SK. Intercycle delays during chemotherapy of non-small cell lung cancer in a health care resource-constrained setting and their effect on overall survival. J Thorac Oncol. 2010;5:236\u20139.","journal-title":"J Thorac Oncol"},{"key":"169_CR23","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1097\/JTO.0b013e318217b623","volume":"6","author":"R Diaconescu","year":"2011","unstructured":"Diaconescu R, Lafond C, Whittom R. Treatment delays in non-small cell lung cancer and their prognostic implications. J Thorac Oncol. 2011;6:1254\u20139.","journal-title":"J Thorac Oncol"},{"key":"169_CR24","doi-asserted-by":"publisher","first-page":"e379","DOI":"10.1016\/j.cllc.2020.05.028","volume":"22","author":"K Sehgal","year":"2021","unstructured":"Sehgal K, Bulumulle A, Brody H, Gill RR, Macherla S, Qilleri A, et al. Association of extended dosing intervals or delays in pembrolizumab-based regimens with survival outcomes in advanced non-small-cell lung cancer. Clin Lung Cancer. 2021;22:e379\u201389.","journal-title":"Clin Lung Cancer"},{"key":"169_CR25","unstructured":"Wikipedia. Religion in the Republic of Ireland. 2025. https:\/\/en.wikipedia.org\/wiki\/Religion_in_the_Republic_of_Ireland."},{"key":"169_CR26","unstructured":"Observer LLL. Ireland\u2019s top Christmas traditions revealed in new survey 2021. 2025. https:\/\/www.leitrimobserver.ie\/news\/christmas-in-leitrim\/705920\/ireland-s-top-christmas-traditions-revealed-in-new-survey.html."},{"key":"169_CR27","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4103\/aca.ACA_157_18","volume":"22","author":"P Mishra","year":"2019","unstructured":"Mishra P, Pandey CM, Singh U, Gupta A, Sahu C, Keshri A. Descriptive statistics and normality tests for statistical data. Ann Card Anaesth. 2019;22:67\u201372.","journal-title":"Ann Card Anaesth"},{"key":"169_CR28","unstructured":"European Society of Medical Oncology. ESMO designated Centres of Integrated Oncology and Palliative Care Accreditation Programme. 2024. https:\/\/www.esmo.org\/for-patients\/esmo-designated-centres-of-integrated-oncology-palliative-care\/esmo-designated-centres-accreditation-programme."},{"key":"169_CR29","unstructured":"Department of Health. National Cancer Strategy 2017\u20132026. Dublin, Ireland; 2017. https:\/\/assets.gov.ie\/static\/documents\/national-cancer-strategy-2017-2026.pdf."},{"key":"169_CR30","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/S1470-2045(16)30383-7","volume":"17","author":"M Wallington","year":"2016","unstructured":"Wallington M, Saxon EB, Bomb M, Smittenaar R, Wickenden M, McPhail S, et al. 30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study. Lancet Oncol. 2016;17:1203\u201316.","journal-title":"Lancet Oncol"},{"key":"169_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12904-022-00910-x","volume":"21","author":"I Woldie","year":"2022","unstructured":"Woldie I, Elfiki T, Kulkarni S, Springer C, McArthur E, Freeman N. Chemotherapy during the last 30 days of life and the role of palliative care referral, a single center experience. BMC Palliat Care. 2022;21:20.","journal-title":"BMC Palliat Care"},{"key":"169_CR32","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_432524","volume":"44","author":"N Frost","year":"2024","unstructured":"Frost N, Reck M. Non-small cell lung cancer metastatic without oncogenic alterations. Am Soc Clin Oncol Educ Book. 2024;44:e432524.","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"169_CR33","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1056\/NEJMoa1000678","volume":"363","author":"JS Temel","year":"2010","unstructured":"Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363:733\u201342.","journal-title":"N Engl J Med"},{"key":"169_CR34","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1089\/jpm.2020.0782","volume":"24","author":"JJ Sanders","year":"2021","unstructured":"Sanders JJ. Reflections on goal-concordant care: a Christmas story. J Palliat Med. 2021;24:329\u201330.","journal-title":"J Palliat Med"},{"key":"169_CR35","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1089\/jpm.2017.0459","volume":"21","author":"JJ Sanders","year":"2018","unstructured":"Sanders JJ, Curtis JR, Tulsky JA. Achieving goal-concordant care: a conceptual model and approach to measuring serious illness communication and its impact. J Palliat Med. 2018;21:S17\u201327.","journal-title":"J Palliat Med"},{"key":"169_CR36","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1007\/s11606-012-2077-6","volume":"27","author":"G Elwyn","year":"2012","unstructured":"Elwyn G, Frosch D, Thomson R, Joseph-Williams N, Lloyd A, Kinnersley P, et al. Shared decision making: a model for clinical practice. J Gen Intern Med. 2012;27:1361\u20137.","journal-title":"J Gen Intern Med"},{"key":"169_CR37","doi-asserted-by":"publisher","first-page":"a752","DOI":"10.1136\/bmj.a752","volume":"337","author":"S Audrey","year":"2008","unstructured":"Audrey S, Abel J, Blazeby JM, Falk S, Campbell R. What oncologists tell patients about survival benefits of palliative chemotherapy and implications for informed consent: qualitative study. BMJ. 2008;337:a752.","journal-title":"BMJ"},{"key":"169_CR38","doi-asserted-by":"crossref","unstructured":"Nelson A, Longo M, Byrne A, Sivell S, Noble S, Lester J, et al. Chemotherapy decision-making in advanced lung cancer: a prospective qualitative study. BMJ Support Palliat Care. 2024;14:e758\u2013e764.","DOI":"10.1136\/bmjspcare-2020-002395"},{"key":"169_CR39","doi-asserted-by":"publisher","first-page":"m3904","DOI":"10.1136\/bmj.m3904","volume":"371","author":"S Sundar","year":"2020","unstructured":"Sundar S. In defence of hope. BMJ. 2020;371:m3904.","journal-title":"BMJ"},{"key":"169_CR40","doi-asserted-by":"publisher","first-page":"e076625","DOI":"10.1136\/bmj-2023-076625","volume":"384","author":"ECT Geijteman","year":"2024","unstructured":"Geijteman ECT, Kuip EJM, Oskam J, Lees D, Bruera E. Illness trajectories of incurable solid cancers. BMJ. 2024;384:e076625.","journal-title":"BMJ"},{"key":"169_CR41","doi-asserted-by":"crossref","unstructured":"Gaynor S, Mulvaney E, Weadick C, Greally H, Keogh RJ, O\u2019Meara Y, et al. Self-expressed needs and gaps in our care of metastatic breast cancer (MBC): an all-Ireland patient-led online survey (CTRIAL-IE 23-05). J Clin Oncol. 2024;42:12058.","DOI":"10.1200\/JCO.2024.42.16_suppl.12058"},{"key":"169_CR42","doi-asserted-by":"crossref","unstructured":"Weadick C, Gaynor S, Mulvaney E, Duane FK, Keogh R, Greally H, et al. Identifying the communication needs of people living with metastatic breast cancer (MBC) in Ireland: an all-Ireland patient-led survey (CTRIAL-IE 23-05). ESMO Open. 2024;9:103264.","DOI":"10.1016\/j.esmoop.2024.103264"},{"key":"169_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12904-015-0035-x","volume":"14","author":"AL Roze des Ordons","year":"2015","unstructured":"Roze des Ordons AL, Sharma N, Heyland DK, You JJ. Strategies for effective goals of care discussions and decision-making: perspectives from a multi-centre survey of Canadian hospital-based healthcare providers. BMC Palliat Care. 2015;14:38.","journal-title":"BMC Palliat Care"},{"key":"169_CR44","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1200\/JCO.2010.32.4459","volume":"29","author":"JS Temel","year":"2011","unstructured":"Temel JS, Greer JA, Admane S, Gallagher ER, Jackson VA, Lynch TJ, et al. Longitudinal perceptions of prognosis and goals of therapy in patients with metastatic non-small-cell lung cancer: results of a randomized study of early palliative care. J Clin Oncol. 2011;29:2319\u201326.","journal-title":"J Clin Oncol"},{"key":"169_CR45","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.breast.2014.08.009","volume":"23","author":"F Cardoso","year":"2014","unstructured":"Cardoso F, Costa A, Norton L, Senkus E, Aapro M, Andr\u00e9 F, et al. ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2). Breast. 2014;23:489\u2013502.","journal-title":"Breast"},{"key":"169_CR46","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s11845-017-1579-y","volume":"186","author":"D Kelly","year":"2017","unstructured":"Kelly D, Mc Sorley L, O\u2019Shea E, Mc Carthy E, Bowe S, Brady C, et al. A regional analysis of epidermal growth factor receptor (EGFR) mutated lung cancer for HSE South. Ir J Med Sci. 2017;186:855\u20137.","journal-title":"Ir J Med Sci"},{"key":"169_CR47","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s11845-018-1868-0","volume":"188","author":"D Kelly","year":"2019","unstructured":"Kelly D, Burke L, O\u2019Brien C, Kearns R, Rafee S, Power D, et al. Co-occurrence of EGFR sensitising and resistance mutations at diagnosis in NSCLC. Ir J Med Sci. 2019;188:405\u20138.","journal-title":"Ir J Med Sci"},{"key":"169_CR48","first-page":"Cd001431","volume":"1","author":"D Stacey","year":"2024","unstructured":"Stacey D, Lewis KB, Smith M, Carley M, Volk R, Douglas EE, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2024;1:Cd001431.","journal-title":"Cochrane Database Syst Rev"},{"key":"169_CR49","unstructured":"Kalanithi P. When breath becomes air. 1st ed. London, England: Bodley Head; 2016."}],"container-title":["BJC Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44276-025-00169-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44276-025-00169-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44276-025-00169-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T12:29:04Z","timestamp":1763641744000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44276-025-00169-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["169"],"URL":"https:\/\/doi.org\/10.1038\/s44276-025-00169-8","relation":{},"ISSN":["2731-9377"],"issn-type":[{"value":"2731-9377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"1 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"SOR is Deputy Editor for BJC Reports and and recused himself from all decisions about this paper. The authors declare no other competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The Clinical Research Ethics Committee of the Cork Teaching Hospitals provided ethical approval (reference number: ECM4 (v) 14\/05\/2024). Consent from participants was waived due to the retrospective nature of the study. The study was performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"71"}}